72,234 articles
Mevalonate pathway
Mevalonate pathway: cytosolic/ER route from acetyl-CoA to IPP, cholesterol, dolichol, ubiquinone, and prenylated proteins; HMG-CoA reductase is rate-limiting and the statin target; also called HMG-CoA reductase pathway.
Mevinphos
Mevinphos (Phosdrin, CAS 7786-34-7), an organophosphate cholinesterase-inhibitor insecticide, EPA Category I, WHO extremely hazardous, used on vegetables and fruits, withdrawn from US domestic production.
Mevonlerbart
Mevonlerbart (REGN1909) is a fully human monoclonal antibody from Regeneron that binds Fel d 1, the dominant cat allergen, and is in Phase 3 development for cat allergy.
Mewing (orthotropics)
Mewing: tongue-on-palate posture technique from John Mew's orthotropics, viral on social media for jawline reshaping; orthodontic bodies find no scientific evidence and cite risks.
MeWo
MeWo (CVCL_0445; also MEWO, SK-MEL-MeWo, BI-Mel) is a human cutaneous melanoma cell line from a metastatic lymph node of a 78-year-old man, established at Memorial Sloan Kettering and first published in 1976; NF1-mutant, microsatellite stable, CDKN2A-deficient.
Mexican free-tailed bat
Mexican free-tailed bat (Tadarida brasiliensis, Brazilian free-tailed bat), a fast migratory molossid bat of the Americas forming huge Texas cave colonies such as Bracken Cave, eating agricultural pest insects and named Texas state flying mammal in 1995.
Mexican grizzly bear
The Mexican grizzly bear (Ursus arctos nelsoni), or oso plateado, was a large brown bear of northern Mexico and the southwestern United States, hunted and poisoned to extinction around 1964.
Mexican lapdog
Mexican lapdog: a term meaning the Chihuahua (smallest breed, under 6 lb), the toy Xoloitzcuintli (10-15 lb), or an extinct guinea-pig-sized historical breed of that exact name from Mexico.
Mexican long-nosed armadillo
Mexican long-nosed armadillo (Dasypus mexicanus), also called nine-banded armadillo: an armadillo from the central-eastern US to Costa Rica, split from D. novemcinctus by genetics, with 7–11 bands, polyembryony, and IUCN Least Concern status.
Mexican raccoon
Mexican raccoon is an informal name usually applied to the white-nosed coati (Nasua narica, tejón), though Mexico's true raccoons are Procyon lotor and the Critically Endangered Cozumel-endemic pygmy raccoon Procyon pygmaeus.
Mexican wolf
Mexican wolf (Canis lupus baileyi, lobo): smallest, rarest, most genetically distinct gray wolf subspecies of North America; extirpated by the 1970s, saved by captive breeding, reintroduced in 1998 (US) and 2011 (Mexico); 319 wild wolves by 2025.
Mexico APL study
Mexico APL study (NCT04562818), a retrospective multicenter study by Instituto Nacional de Cancerologia de Mexico of 360 acute promyelocytic leukemia patients treated 2007-2017 with anthracycline plus ATRA, reporting 84% overall survival at 150 months.
Meyer B. Jackson
Meyer B. Jackson is an American neuroscientist and biophysicist who holds the Kenneth S. Cole Professorship at the University of Wisconsin–Madison, known for treating fusion pores like ion channels.
Meyer lemon
Meyer lemon (Citrus × meyeri), a Chinese lemon-orange hybrid brought to the US by Frank Meyer in 1908; sweeter, thinner-skinned, and hardier than true lemons, sold today as the virus-free Improved Meyer after UC Riverside's 1970s clean-up of tristeza virus carriers.
Mezigdomide
Mezigdomide (CC-92480, BMS-986348) is an oral cereblon E3 ligase modulator (CELMoD) degrading Ikaros/Aiolos, investigated for relapsed/refractory multiple myeloma; SUCCESSOR-2 showed PFS 18.0 vs 8.3 months, FDA NDA accepted 2026.
Mezlocillin
Mezlocillin (Mezlin, Baypen, BAY-F-1353) is a semisynthetic ureidopenicillin beta-lactam antibiotic developed by Bayer, FDA approved in 1981, given parenterally for serious gram-negative infections, and discontinued in the U.S.
Mff-like domain
Mff-like domain (InterPro IPR039433), a coiled-coil plus transmembrane domain in mitochondrial fission factor (Mff) and the C terminus of FATE1; in Mff it supports Drp1 recruitment for mitochondrial and peroxisomal fission.
MFGE8
MFGE8 (milk fat globule-EGF factor 8, lactadherin, SED1) is a secreted 46 kDa glycoprotein bridging phosphatidylserine on apoptotic cells to αvβ3/αvβ5 integrins on phagocytes, enabling efferocytosis and VEGF-dependent angiogenesis; overexpressed in several cancers.
MFN1
MFN1 (mitofusin 1, hfzo1) is a human protein-coding gene at 3q26.33 encoding a 741-residue outer mitochondrial membrane GTPase that mediates mitochondrial fusion, with higher GTPase activity than MFN2.
MFN2
MFN2 (mitofusin 2, OMIM 608507, aliases CMT2A2, MARF) is a gene at 1p36.22 encoding an outer mitochondrial membrane GTPase that mediates mitochondrial fusion; pathogenic variants cause CMT2A, HMSN VIA, and recessive lipodystrophy.
MG-132
MG-132, also known as Z-Leu-Leu-Leu-al, is a cell-permeable tripeptide aldehyde that reversibly inhibits the 26S proteasome, making it the most widely used proteasome inhibitor in laboratory research despite never being developed as a drug.
MG-63
MG-63 (MG63, CVCL_0426) is a human osteosarcoma cell line from a 14-year-old male, left femur, reported 1977 as an interferon producer; an osteoblast-like model that does not mineralize.
MGAP-GAP study
MGAP-GAP study (NCT06732791): prospective observational cohort at Al-Kadhimiya Teaching Hospital, Baghdad, comparing MGAP and GAP trauma scores for predicting mortality, ICU admission, and surgery in multiple trauma patients; 522 participants, 2025-2027, Al-Nahrain University.
MGAR
MGAR (CVCL_E775, ECACC 88022014) is an EBV-transformed human B-lymphoblastoid cell line from a Hispanic female donor, part of the 10th International Histocompatibility Workshop panel, HLA-typed A*26:01, B*08:01, C*07:01, DRB1*15:01.
MGAT2-CDG
MGAT2-CDG (formerly CDG-IIa, Alkuraya syndrome) is an autosomal recessive congenital disorder of glycosylation caused by MGAT2 loss-of-function mutations at 14q21, causing facial dysmorphism, seizures, developmental delay, and bleeding tendency.
MGM-16
MGM-16, or 9-fluoro-dihydro-7-hydroxymitragynine, is a semi-synthetic fluorinated kratom-alkaloid derivative and full μ/δ opioid agonist reported in 2014; potent in mouse pain models, never studied in humans, U.S. Schedule I since August 26, 2026.
MGMT promoter methylation testing
MGMT promoter methylation testing is a clinical biomarker assay that detects methylation of the MGMT gene promoter, used mainly in glioblastoma to predict benefit from temozolomide.
MHC class I
MHC class I (HLA-A, -B, -C and non-classical HLA-E, -F, -G): cell-surface peptide-presenting molecules on nucleated cells, recognized by CD8 T cells and NK receptors, with chaperone-driven peptide loading.
MHC class I-like protein M157, MHC-like domain
m157, MCMV-encoded MHC class I-like GPI-linked glycoprotein decoy; recognized by activating Ly49H (C57BL/6 resistance) and inhibitory Ly49I (129/J susceptibility); MHC-like fold, no peptide or beta2m.
MHC class II
MHC class II (HLA-DP, DQ, DR, DM, DO) are antigen-presenting glycoproteins on professional APCs and thymic epithelial cells that display endosomal peptides to CD4+ T cells, regulated by CIITA and loaded via invariant chain, CLIP, and HLA-DM.